Fertility After Treatment With High Dose Melphalan in Women With Acute Myelogenous Leukemia.


BACKGROUND High-dose melphalan (HDM) is an integral component of conditioning regimens for autologous and allogeneic hematopoietic stem cell transplantation for patients with malignant and non-malignant diseases. The gonadotoxic effects of HDM are often obscured by previous or concurrent administration of alkylating agents. From April 1996 to January 2006… (More)
DOI: 10.1002/pbc.25765